{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:46:43Z","timestamp":1785541603614,"version":"3.56.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.medj.2024.03.014","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T10:39:38Z","timestamp":1712227178000},"page":"735-758.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-2872","authenticated-orcid":false,"given":"Giovanni","family":"Musso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pinach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"De Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cassader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2024.03.014_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.medj.2024.03.014_bib2","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2024.03.014_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/NHH.0000000000001216","article-title":"An Overview of Insulin Therapy in the Management of Diabetes Mellitus","volume":"41","author":"Hayes","year":"2023","journal-title":"Home Healthc. Nurse"},{"key":"10.1016\/j.medj.2024.03.014_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.puhe.2023.10.015","article-title":"The prevalence of glycemic control in patients with type 2 diabetes treated with insulin: a systematic review and meta-analysis","volume":"225","author":"Pitak","year":"2023","journal-title":"Publ. Health"},{"key":"10.1016\/j.medj.2024.03.014_bib5","article-title":"What Is Best for Weight Loss? A Comparative Review of the Safety and Efficacy of Bariatric Surgery Versus Glucagon-Like Peptide-1 Analogue","volume":"15","author":"Klair","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.medj.2024.03.014_bib6","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1152\/ajpendo.00559.2012","article-title":"Nutrient infusion bypassing duodenum jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects","volume":"305","author":"Salinari","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.medj.2024.03.014_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.soard.2013.01.021","article-title":"The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model","volume":"10","author":"Shimizu","year":"2014","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.medj.2024.03.014_bib8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11695-012-0621-4","article-title":"Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2\u00a0weeks after gastric bypass in non-diabetic subjects","volume":"22","author":"Jacobsen","year":"2012","journal-title":"Obes. Surg."},{"key":"10.1016\/j.medj.2024.03.014_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc16-0236","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations","volume":"39","author":"Rubino","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2024.03.014_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11695-022-06379-0","article-title":"The Effectiveness and Safety of the Duodenal-Jejunal Bypass Liner (DJBL) for the Management of Obesity and Glycaemic Control: a Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"33","author":"Yvamoto","year":"2023","journal-title":"Obes. Surg."},{"key":"10.1016\/j.medj.2024.03.014_bib11","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc16-0383","article-title":"Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study","volume":"39","author":"Rajagopalan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2024.03.014_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jhepr.2019.10.006","article-title":"Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results","volume":"1","author":"van Baar","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.medj.2024.03.014_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gutjnl-2019-318349","article-title":"Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study","volume":"69","author":"van Baar","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.medj.2024.03.014_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109194","article-title":"Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)","volume":"184","author":"van Baar","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.medj.2024.03.014_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/gutjnl-2020-323608","article-title":"Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial","volume":"71","author":"Mingrone","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.medj.2024.03.014_bib16","doi-asserted-by":"crossref","first-page":"E1792","DOI":"10.1055\/a-1550-7668","article-title":"Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study","volume":"9","author":"Hadefi","year":"2021","journal-title":"Endosc. Int. Open"},{"key":"10.1016\/j.medj.2024.03.014_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gie.2020.12.021","article-title":"Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study","volume":"94","author":"van Baar","year":"2021","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.medj.2024.03.014_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2337\/db23-824-P","article-title":"Glycemic Improvement, Insulin Reductions, and Improved Body Weight 48 Weeks after Revita Duodenal Mucosal Resurfacing in T2D patients with Previously Inadequately Controlled Glucose Despite Multiple Glucose-Lowering Agents Including Insulin","volume":"72","author":"Fonseca","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.medj.2024.03.014_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154908","article-title":"Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome","volume":"125","author":"Kaur","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.medj.2024.03.014_bib20","doi-asserted-by":"crossref","first-page":"835-","DOI":"10.2337\/db23-835-P","article-title":"First-in-Human Duodenal Endoscopic Recellularization via Electroporation Therapy for Type 2 Diabetes","volume":"72","author":"Yuan","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.medj.2024.03.014_bib21","article-title":"RE-CELLULARIZATION VIA ELECTROPORATION THERAPY (RECET) COMBINED WITH GLP-1RA TO REPLACE INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES 6 MONTHS RESULTS OF THE EMINENT STUDY Gastrointestinal","volume":"97","author":"Busch","year":"2023","journal-title":"Endoscopy"},{"key":"10.1016\/j.medj.2024.03.014_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2020.101483","article-title":"S-methyl cysteine sulfoxide ameliorates duodenal morphological alterations in streptozotocin-induced diabetic rats","volume":"69","author":"Castro","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.medj.2024.03.014_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00592-019-01436-0","article-title":"Modulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated mice","volume":"57","author":"Wang","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.medj.2024.03.014_bib24","first-page":"S42","article-title":"The mechanisms of duodenal mucosal resurfacing procedure in reversing type 2 diabetes","volume":"66","author":"LiJuan","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.medj.2024.03.014_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2337\/db18-1900-P","article-title":"Westernized diet induced insulin resistance in mice is associated with focal duodenal hyperplasia","volume":"67","author":"Ghosh","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.medj.2024.03.014_bib26","article-title":"Small intestine remodeling in male Goto-Kakizaki rats","volume":"9","author":"Pereira","year":"2021","journal-title":"Phys. Rep."},{"key":"10.1016\/j.medj.2024.03.014_bib27","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00310.2001","article-title":"Expression of monosaccharide transporters in intestine of diabetic humans","volume":"282","author":"Dyer","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.medj.2024.03.014_bib28","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1053\/j.gastro.2019.01.262","article-title":"Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy","volume":"156","author":"Svane","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.medj.2024.03.014_bib29","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2017-00348","article-title":"Duodenal Sodium\/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia","volume":"102","author":"Fiorentino","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.medj.2024.03.014_bib30","first-page":"417","article-title":"Dumping syndrome after bariatric surgery: prevalence, pathophysiology and role in weight reduction - a systematic review","volume":"86","author":"D'hoedt","year":"2023","journal-title":"Acta Gastroenterol. Belg."},{"key":"10.1016\/j.medj.2024.03.014_bib31","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.3390\/nu15173707","article-title":"An Association between Decreased Small Intestinal RNA Modification and Disturbed Glucagon-like Peptide-1 Secretion under High-Fat Diet Stress","volume":"24","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.medj.2024.03.014_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.medj.2024.03.014_bib33","doi-asserted-by":"crossref","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsboll","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.medj.2024.03.014_bib34","doi-asserted-by":"crossref","first-page":"R657","DOI":"10.1152\/ajpregu.00345.2011","article-title":"Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus","volume":"302","author":"Lee","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.medj.2024.03.014_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-017-4450-9","article-title":"Enteroendocrine K and L cells in healthy and type 2 diabetic individuals","volume":"61","author":"Jorsal","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.medj.2024.03.014_bib36","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","article-title":"Incretin hormones and type 2 diabetes","volume":"66","author":"Nauck","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.medj.2024.03.014_bib37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00125-022-05715-4","article-title":"Management of type 2 diabetes with the dual GIP\/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis","volume":"65","author":"Karagiannis","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.medj.2024.03.014_bib38","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/dom.15365","article-title":"Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes","volume":"26","author":"Mather","year":"2024","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.medj.2024.03.014_bib39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3945\/ajcn.113.063792","article-title":"Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism","volume":"98","author":"Musso","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.medj.2024.03.014_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113305","article-title":"High-calorie diets uncouple hypothalamic oxytocin neurons from a gut-to-brain satiation pathway via \u03ba-opioid signaling","volume":"42","author":"Gruber","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2024.03.014_bib41","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00134.2014","article-title":"Characterization of duodenal expression and localization of fatty acid-sensing receptors in humans: relationships with body mass index","volume":"307","author":"Little","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.medj.2024.03.014_bib42","first-page":"3359e3374","article-title":"High-fat diet induces disruption of the tight junction-mediated paracellular barrier in the proximal small intestine before the onset of type 2 diabetes and endotoxemia","volume":"66","author":"Nascimento","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.medj.2024.03.014_bib43","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.32235","article-title":"A GLP-1\/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome","volume":"75","author":"Kim","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2024.03.014_bib44","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s11695-022-06328-x","article-title":"Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass","volume":"32","author":"P\u00e9rez-Arana","year":"2022","journal-title":"Obes. Surg."},{"key":"10.1016\/j.medj.2024.03.014_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/thoraxjnl-2015-206782","article-title":"Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver","volume":"70","author":"Nobili","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.medj.2024.03.014_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/jcm9020369","article-title":"Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: a pilot study","volume":"9","author":"Sroka-Oleksiak","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.medj.2024.03.014_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-med-012510-175505","article-title":"Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes","volume":"62","author":"Musso","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.medj.2024.03.014_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41522-019-0101-x","article-title":"Blautia genus associated with visceral fat accumulation in adults 20\u201376 years of age","volume":"5","author":"Ozato","year":"2019","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.medj.2024.03.014_bib49","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gutjnl-2019-318320","article-title":"Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time","volume":"69","author":"de Groot","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.medj.2024.03.014_bib50","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","article-title":"Gut microbiota Turicibacter strains differentially modify bile acids and host lipids","volume":"14","author":"Lynch","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2024.03.014_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.112309","article-title":"Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function","volume":"163","author":"Yang","year":"2023","journal-title":"Food Res. Int."},{"key":"10.1016\/j.medj.2024.03.014_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1181744","article-title":"A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass","volume":"14","author":"Hern\u00e1ndez-Montoliu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.medj.2024.03.014_bib53","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/microorganisms10102061","article-title":"GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk","volume":"10","author":"Abdalqadir","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.medj.2024.03.014_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105337","article-title":"Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice","volume":"163","author":"Sugama","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.medj.2024.03.014_bib55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.32742","article-title":"Fibroblast growth factor receptor 1\/Klotho\u03b2 agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial","volume":"78","author":"Wong","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2024.03.014_bib56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/acs.jafc.3c02909","article-title":"High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice","volume":"72","author":"He","year":"2024","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.medj.2024.03.014_bib57","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2024.03.014_bib58","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.23408","article-title":"Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice","volume":"51","author":"Herrema","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2024.03.014_bib59","series-title":"SAGES 2019 annual meeting","article-title":"Duodenal Mucosal resurfacing: where do we stand?","author":"Galvao Neto","year":"2019"},{"key":"10.1016\/j.medj.2024.03.014_bib60","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1152\/ajpendo.00337.2021","article-title":"Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes","volume":"322","author":"Meiring","year":"2022","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.medj.2024.03.014_bib61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.gie.2019.03.024","article-title":"Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting","volume":"90","author":"Haidry","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.medj.2024.03.014_bib62","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1055\/a-0862-0263","article-title":"Histologic assessment of the intestinal wall following duodenal mucosal resurfacing (DMR): a new procedure for the treatment of insulin-resistant metabolic disease","volume":"7","author":"de Moura","year":"2019","journal-title":"Endosc. Int. Open"},{"key":"10.1016\/j.medj.2024.03.014_bib63","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/db13-1307","article-title":"Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass","volume":"63","author":"Bojsen-M\u00f8ller","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.medj.2024.03.014_bib64","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.medj.2024.03.014_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1363.007","article-title":"Cell injury by electric forces","volume":"1066","author":"Lee","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.medj.2024.03.014_bib66","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1021\/ja029504i","article-title":"Simulation of pore formation in lipid bilayers by mechanical stress and electric felds","volume":"125","author":"Tieleman","year":"2003","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.medj.2024.03.014_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2019.05.036","article-title":"High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity","volume":"44","author":"Ringel-Scaia","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.medj.2024.03.014_bib68","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jso.23280","article-title":"Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures","volume":"107","author":"Cannon","year":"2013","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.medj.2024.03.014_bib69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0065-2660(05)54005-7","article-title":"Electric pulse-mediated gene delivery to various animal tissues","volume":"54","author":"Mir","year":"2005","journal-title":"Adv. Genet."},{"key":"10.1016\/j.medj.2024.03.014_bib70","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-5-115","article-title":"Radiosensitising efect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice","volume":"5","author":"Kranjc","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.medj.2024.03.014_bib71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/153303460700600401","article-title":"Irreversible electroporation in medicine","volume":"6","author":"Rubinsky","year":"2007","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.medj.2024.03.014_bib72","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2020192190","article-title":"High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.medj.2024.03.014_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-023-01660-3","article-title":"Pulsed field ablation versus thermal energy ablation for atrial fibrillation: a systematic review and meta-analysis of procedural efficiency, safety, and efficacy","author":"Aldaas","year":"2023","journal-title":"J.\u00a0Intervent. Card Electrophysiol."},{"key":"10.1016\/j.medj.2024.03.014_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00592-022-01974-0","article-title":"De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes","volume":"60","author":"Falcetta","year":"2023","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.medj.2024.03.014_bib75","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy\u00a0\u2013 mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.medj.2024.03.014_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103733","article-title":"Duodenal mucosal resurfacing with photodynamic therapy using methylene blue in a mouse model","volume":"44","author":"Yang","year":"2023","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.medj.2024.03.014_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122336","article-title":"Surfactant-like photosensitizer for endoscopic duodenal ablation: Modulating meal-stimulated incretin hormones in obese and type 2 diabetes","volume":"302","author":"Lee","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.medj.2024.03.014_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119977","article-title":"Lipid photosensitizers for suppression of gastric inhibitory polypeptide in obese with type 2 diabetes","volume":"246","author":"Lee","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.medj.2024.03.014_bib79","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1467-789X.2011.00897.x","article-title":"Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders","volume":"12","author":"Paschetta","year":"2011","journal-title":"Obes. Rev."},{"key":"10.1016\/j.medj.2024.03.014_bib80","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3945\/ajcn.2008.26720","article-title":"Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver","volume":"89","author":"Musso","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.medj.2024.03.014_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115119","article-title":"PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD)","volume":"202","author":"Liu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.medj.2024.03.014_bib82","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1572-0241.2008.01888.x","article-title":"Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis","volume":"103","author":"Floreani","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.medj.2024.03.014_bib83","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/diacare.25.8.1410","article-title":"Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61","volume":"25","author":"Colagiuri","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2024.03.014_bib84","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2024.03.014_bib85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MOL.0b013e32834c37ee","article-title":"Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update","volume":"22","author":"Musso","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.medj.2024.03.014_bib86","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.medj.2024.03.014_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.medj.2024.03.014_bib88","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/hep.30672","article-title":"Liver Forum Case Definitions Working Group. Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum","volume":"70","author":"Cheung","year":"2019","journal-title":"Hepatology"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:18:56Z","timestamp":1752589136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634024001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2666634024001260"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2024.03.014","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2024.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}